Home Pilots Cue Health receives first-ever de novo authorization for at-home COVID test Pilots Cue Health receives first-ever de novo authorization for at-home COVID test By - June 8, 2023 25 0 Facebook Twitter Pinterest WhatsApp The company was also the first to receive emergency use authorization for its home COVID test in 2021. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Roundup: Global Health joins Asta Swisstec’s project in NT and more briefs Pilots - April 14, 2022 0 Life science companies unite on AI efforts through Israel’s Aion Lab Pilots - February 18, 2022 0 Pear Therapeutics expands partnership with outpatient addiction treatment clinics Pilots - January 4, 2023 0 Roundup: First insomnia DTx in South Korea gets regulatory nod and more briefs Pilots - February 17, 2023 0 Grocery delivery company Instacart launches health division Pilots - September 28, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3